| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |